Michael Salant Hellerstein

1 Patent

• US117014182023

  Replication-deficient Modified Vaccinia Ankara (MVA) Expressing Ebola Virus Glycoprotein (GP) and Matrix Protein (VP40)

  Geovax, Inc.

  0 cites